Lv7
5000 积分 2024-09-13 加入
Comparative efficacy of anti‐CD38 monoclonal antibodies in multiple myeloma using a network meta‐analysis
1个月前
已完结
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
1个月前
已完结
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
1个月前
已关闭
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study
1个月前
已完结
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study
1个月前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
1个月前
已完结
Perspectives on Newly Diagnosed Myeloma Treatment and Emerging Challenges
1个月前
已完结
Isatuximab: A Review in Transplant-Ineligible Newly Diagnosed Multiple Myeloma
1个月前
已完结
Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper
1个月前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
1个月前
已完结
皖公网安备34019202002308
